Utah Medical Products, Inc.
UTMD
$58.72
$0.390.67%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | 3.56M | 3.45M | 3.96M | 4.29M | 3.94M |
Total Depreciation and Amortization | 740.00K | 693.00K | 683.00K | 1.04M | 1.79M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 0.00 | -107.00K | -112.00K | -339.00K | -96.00K |
Change in Net Operating Assets | -447.00K | -1.28M | 749.00K | 345.00K | -503.00K |
Cash from Operations | 3.86M | 2.76M | 5.28M | 5.33M | 5.12M |
Capital Expenditure | -89.00K | -110.00K | -22.00K | -90.00K | -186.00K |
Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 27.00K | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.00 | -5.00K | -- | -- | -- |
Cash from Investing | -89.00K | -115.00K | 5.00K | -90.00K | -186.00K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 0.00 | 294.00K | 96.00K | 0.00 | 36.00K |
Repurchase of Common Stock | -3.87M | -6.40M | -2.99M | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -1.05M | -1.08M | -1.09M | -1.07M | -1.07M |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -4.92M | -7.19M | -3.98M | -1.07M | -1.04M |
Foreign Exchange rate Adjustments | 384.00K | -46.00K | -358.00K | 488.00K | -310.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -767.00K | -4.59M | 940.00K | 4.66M | 3.59M |